<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66-marinedrugs-17-00373">
 <label>66.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fazekas</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Eickhoff</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Pruckner</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Vollnhofer</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Fischmeister</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Diakos</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Rauch</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Verdianz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zoubek</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gadner</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold</article-title>
  <source>BMC Complement. Altern. Med.</source>
  <year>2012</year>
  <volume>12</volume>
  <elocation-id>147</elocation-id>
  <pub-id pub-id-type="doi">10.1186/1472-6882-12-147</pub-id>
  <?supplied-pmid 22950667?>
  <pub-id pub-id-type="pmid">22950667</pub-id>
 </element-citation>
</ref>
